CLDN1 and breast neoplasm: To determine whether claudin 1 protein levels were associated with the presence (or absence) of CLDN1 transcript variants, immunohistochemical (IHC) analysis of breast tumors was determined using a c-terminal claudin 1 polyclonal antibody.